News

Published on 3 Apr 2024 on Zacks via Yahoo Finance

Wall Street Set to See a Broad-Based Rally in Q2: 5 Picks


Article preview image

U.S. stock markets have been witnessing an astonishing rally in the past 15 months. However, the major driver of this rally was globally booming artificial intelligence (AI), especially generative AI. Companies that have extensive applications of AI in their final products have become multi-baggers in the past 15 months. Stock prices of some of these companies have skyrocketed 200-300% during this period.

These highly overvalued stocks make a large section of financial researchers and analysts skeptical of investing, although the near-term business outlook of these entities remains solid. Their current overstretched valuation makes them less attractive to investors.

Market participants are shifting more toward cyclical sectors like industrials, financials, energy, materials and transportation, to name a few. Consequently, the Wall Street bull run has become more broad-based. This trend is likely to gather pace in the second quarter of 2024.

NYSE.GIS price evolution
NYSE.WELL price evolution
NYSE.ELV price evolution
NASDAQ.RYAAY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Investing in Elevance Health (NYSE:ELV) five years ago would have delivered you a 118% gain

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But o...

Simply Wall St. via Yahoo Finance 27 Apr 2024

Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity

For Immediate Release Chicago, IL – April 26, 2024 – Today, Zacks Equity Research discusses Eleva...

Zacks via Yahoo Finance 26 Apr 2024

Elevance Health EVP sells over $10 million in company stock By Investing.com

Elevance Health, Inc. (NYSE:ELV) executive Felicia F. Norwood, who serves as the company's EVP &...

Investing.com 26 Apr 2024

Elevance Health Inc EVP & President, Gov Health Felicia Norwood Sells 20,310 Shares

Elevance Health Inc (NYSE:ELV), formerly known as Anthem Inc, is a health benefits company that i...

GuruFocus.com via Yahoo Finance 26 Apr 2024

Elevance stock target increased, maintains Buy rating on strategic partnerships By Investing.com

On Wednesday, Mizuho Securities adjusted its financial outlook on Elevance Health Inc (NYSE:ELV),...

Investing.com 25 Apr 2024

Elevance Health (NYSE:ELV) Will Pay A Dividend Of $1.63

The board of Elevance Health, Inc. (NYSE:ELV) has announced that it will pay a dividend of $1.63 ...

Simply Wall St. via Yahoo Finance 22 Apr 2024

Elevance Health Inc. (NYSE:ELV) Q1 2024 Earnings Call Transcript

Elevance Health Inc. (NYSE:ELV) Q1 2024 Earnings Call Transcript April 18, 2024 Elevance Health I...

Insider Monkey via Yahoo Finance 19 Apr 2024

Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight

ELV showcases robust revenue growth and shareholder net income increase in Q1 2024.Strong market ...

GuruFocus.com via Yahoo Finance 19 Apr 2024

Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual...

Elevance Health Inc. ELV reported first-quarter revenues of $42.3 billion, up 0.9% year over year...

Benzinga 19 Apr 2024

Elevance (ELV) Q1 Earnings Beat on Rate Hikes, Guidance Raised

Elevance Health, Inc. ELV reported first-quarter 2024 adjusted earnings of $10.64 per share, whic...

Zacks via Yahoo Finance 18 Apr 2024